GFN•TV will bring the conference's platform for rational and inclusive debate on the future role of safer nicotine products and tobacco harm reduction to an audience all year round. GFN•TV will also be broadcasting live from Warsaw in June. Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments. From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.
Rating the evidence - good and bad science - Panel Discussion #3 | #GFN24
The hosts, together with a panel representing scientists, consumers and other stakeholders will review a selection of scientific papers, published in the past 12 months, on nicotine and THR-related issues, identifying the best and worst examples.
GFN 2024 Panel Discussion #3 - hosted by Clive Bates with panellists: Arielle Selya, Gizelle Baker and Roberto Sussman.
📅 22 Jul 2024
REASONS TO BE CHEERFUL | GFN24 Commentary Team hosted by Harry Shapiro
Harry Shapiro is joined by Lindsey Stroud and David Sweanor for this Commentary Team session, filmed at the 2024 edition of the Global Forum on Nicotine!
📅 19 Jul 2024
GFN.TV Interviews | DEMAND DELUSION | PMI On the Battle for A Smoke-Free Future
Philip Morris International is at the centre of the battle over the coming smoke-free world, having spent billions transitioning to reduced-risk products like oral tobacco, heated tobacco products, and vaping. Yet they are still one of the largest producers of combustible tobacco products. How is the journey to the smoke free future going?
Featuring: Ondrej Koumal Director External Affairs, Philip Morris International pmiscience.com
📅 16 Jul 2024
Legislation and regulation - health and economic consequences - Panel Discussion #2 | #GFN24
An examination of the health and economic impact of tobacco control measures and the role for proportionate regulation and risk management for alternative nicotine products.
Global Forum on Nicotine 2024 Panel Discussion #2 - hosted by Clive Bates with panellists: David Sweanor, Nevena Crljenko, Konstantinos Farsalinos and Joe Thompson.
📅 12 Jul 2024
Over a billion consumers, over a trillion dollars a year... | #GFNVoices2024
Fiona Patten, David Sweanor and Ethan Nadelmann joins us in the first episode of this years GFN Voices series.
📅 9 Jul 2024
The costs of prohibition - Panel Discussion #1 | #GFN24
An examination of the health, social and economic costs of prohibition, with a panel reflecting on parallel experiences with illicit drugs and alcohol. The panel comprises politicians, thought leaders from the drug and alcohol fields and a consumer/vape trader perspective.
GFN 2024 Panel Discussion #1 - hosted by Ethan Nadelmann with panellists: Fiona Patten, Lindsey Stroud, Sharifa Ezat Wan Puteh, Harry Shapiro
📅 5 Jul 2024
GFN.TV Interviews | HIGH BURDEN | Illicit Combustible Tobacco & Vapes Take Toll on Malaysia
Nicotine vapes as a tool for harm reduction are gaining support in the Southeast Asian country of Malaysia. However, an entrenched illicit combustible tobacco market is making illegal nicotine vapes highly available and dramatically cheaper than those sold legally. This situation presents a significant challenge for health advocates to overcome.
Featuring: Prof., Dr. Sharifa Ezat Wan Puteh Physician, Prof. Public Health, National University of Malaysia Chairman of the Malaysia Society of Harm Reduction
GFN 2024 Keynote #3 given by Vivien Azer, hosted by David Sweanor, response from Jonathan Fell
Vivien is a nicotine market specialist, and until recently, the Managing Director & Senior Analyst, Global Beverages, Tobacco and Cannabis, at TD Cowen, in New York City. In her keynote she will address a number of themes, among them:
- What factors prompted and drove initial investment in this field? - What is the state of the current market? - Who are the major investors/stakeholders? - What might be the impact of regulation – and possible prohibition – on future investment and the - development of the next generation of safer nicotine products? - Are there lessons to be learnt from other emerging markets, for example the market for medicinal and recreational cannabis?
📅 28 Jun 2024
Michael Russell Award 2024 | #GFN24
Michael Russell Award 2024 - presented to Dr. Colin Mendelsohn by Professor Gerry Stimson
📅 25 Jun 2024
Misinterpretation of the precautionary principle in relation to safer nicotine - Keynote #2 | #GFN24
Whilst no activity has a total absence of risk, science has to embrace risks and challenges to evolve. The over/misinterpretation of the precautionary principle is often an impediment to progress. Drawing on his experience of working with dependence in other fields, Dr McGovern will examine, in relation to nicotine use: - How should we categorise/quantify risk? - Is there a hierarchy of risk(s)? - What are the consequences of avoiding all risks? - How can equivalence assist in assessing risk? - Who should determine the limits of risk – for the individual and communities? - Are there lost opportunities for tobacco harm reduction to have a significant impact on personal and societal health improvement, due to the inappropriate application of the precautionary principle?
